HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anil K Agarwal Selected Research

Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy)

1/2022Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy.
10/2020Absence of AGPAT2 impairs brown adipogenesis, increases IFN stimulated gene expression and alters mitochondrial morphology.
11/2017Metabolic, Reproductive, and Neurologic Abnormalities in Agpat1-Null Mice.
9/2017Juvenile-onset generalized lipodystrophy due to a novel heterozygous missense LMNA mutation affecting lamin C.
2/2014Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors.
6/2009Lipodystrophies: disorders of adipose tissue biology.
9/2008Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability.
12/2005Phenotypic heterogeneity in body fat distribution in patients with atypical Werner's syndrome due to heterozygous Arg133Leu lamin A/C mutation.
10/2003Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.
8/2003Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anil K Agarwal Research Topics

Disease

14Lipodystrophy
01/2022 - 06/2003
13Pathologic Constriction (Stenosis)
01/2021 - 01/2007
12Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy)
01/2022 - 05/2002
10Neoplasms (Cancer)
01/2022 - 11/2006
9Anemia
04/2021 - 11/2006
9Chronic Renal Insufficiency
04/2021 - 01/2002
7Inflammation (Inflammations)
04/2021 - 11/2006
6Obesity
01/2014 - 07/2003
5Progeria (Hutchinson Gilford Syndrome)
10/2020 - 02/2006
5Gallbladder Neoplasms (Gallbladder Cancer)
01/2019 - 10/2007
5Insulin Resistance
07/2017 - 12/2005
4Iron Deficiencies
04/2021 - 11/2006
3Arteriovenous Fistula
11/2020 - 01/2008
3Portal Hypertension
10/2015 - 08/2008
3Heart Failure
01/2013 - 07/2010
2Panniculitis
01/2022 - 12/2010
2Osteoporosis
08/2020 - 03/2008
2Carcinogenesis
08/2019 - 01/2011
2Body Weight (Weight, Body)
11/2017 - 01/2007
2Cardiomyopathies (Cardiomyopathy)
09/2017 - 02/2006
2Muscular Dystrophies (Muscular Dystrophy)
09/2017 - 02/2006
2Type 2 Diabetes Mellitus (MODY)
07/2017 - 01/2004
2Infections
11/2015 - 05/2012
2Adenocarcinoma
07/2015 - 10/2007
2Hyperglycemia
02/2014 - 01/2004
2Hypertriglyceridemia
02/2014 - 12/2005
2Kidney Diseases (Kidney Disease)
06/2013 - 01/2013
2Cholecystitis
01/2013 - 04/2011
2Chronic Kidney Failure (Chronic Renal Failure)
03/2012 - 05/2006
2Cardiovascular Diseases (Cardiovascular Disease)
03/2012 - 01/2007
2Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2011 - 08/2010
2Hyperplasia
09/2009 - 01/2008
2Carcinoma (Carcinomatosis)
12/2007 - 10/2007
2Chronic Pancreatitis
10/2007 - 01/2003
2Familial Partial Lipodystrophy (Dunnigan Syndrome)
05/2003 - 01/2002
1Tuberculosis (Tuberculoses)
09/2021
1Fibrosis (Cirrhosis)
09/2021
1Hypoxia (Hypoxemia)
04/2021
1Biliary Fistula
01/2021
1Osteoarthritis
01/2021
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
12/2019
1Stomach Neoplasms (Stomach Cancer)
08/2019
1Microsatellite Instability
08/2019
1Alcoholic Fatty Liver
01/2019

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
12/2019 - 05/2003
10Lamin Type A (Lamin A)IBA
10/2020 - 05/2003
7EnzymesIBA
12/2016 - 07/2003
6Insulin (Novolin)FDA Link
11/2017 - 12/2005
6Glucose (Dextrose)FDA LinkGeneric
11/2017 - 09/2010
5HematinicsIBA
04/2021 - 03/2009
5IronIBA
04/2021 - 07/2010
4Biomarkers (Surrogate Marker)IBA
04/2021 - 07/2010
4Metalloproteases (Metalloproteinases)IBA
06/2009 - 08/2003
4ZincIBA
06/2009 - 08/2003
31-Acylglycerol-3-Phosphate O-Acyltransferase (1 Acylglycerol 3 Phosphate O Acyltransferase)IBA
10/2020 - 10/2003
3LipidsIBA
01/2019 - 08/2009
3Phospholipids (Phosphatides)FDA LinkGeneric
11/2017 - 07/2003
3Phosphotransferases (Kinase)IBA
01/2017 - 01/2006
3Hemoglobins (Hemoglobin)IBA
03/2012 - 11/2006
3ErythropoietinFDA Link
07/2010 - 11/2006
3Caveolin 1IBA
06/2009 - 04/2008
3PPAR gammaIBA
06/2009 - 01/2002
3Triglycerides (Triacylglycerol)IBA
01/2006 - 05/2002
2AutoantibodiesIBA
01/2022 - 03/2009
2HepcidinsIBA
04/2021 - 01/2019
2Cathepsin DIBA
01/2021 - 01/2019
2LeptinIBA
02/2014 - 10/2003
2CytokinesIBA
01/2014 - 01/2013
2CausticsIBA
10/2013 - 11/2012
2ParaffinIBA
01/2013 - 04/2011
2beta CateninIBA
01/2013 - 04/2011
2Monoclonal AntibodiesIBA
01/2013 - 04/2011
2Protein Isoforms (Isoforms)IBA
08/2012 - 08/2010
2Creatine Kinase (Creatine Phosphokinase)IBA
09/2010 - 09/2008
2Messenger RNA (mRNA)IBA
08/2010 - 01/2004
2Darbepoetin alfa (Aranesp)FDA Link
03/2009 - 05/2008
2GlucocorticoidsIBA
03/2008 - 01/2004
2Indicators and Reagents (Reagents)IBA
12/2007 - 10/2007
2CreatinineIBA
01/2007 - 11/2006
2prelamin AIBA
06/2006 - 09/2005
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2006 - 01/2006
1Perilipin-1IBA
01/2022
1Adenosine DeaminaseIBA
09/2021
1Prolyl-Hydroxylase InhibitorsIBA
04/2021
1Aspartic Acid ProteasesIBA
01/2021
1Growth Hormone (Somatotropin)IBA
08/2020
1DysferlinIBA
12/2019
1Transforming Growth Factor-beta Type II ReceptorIBA
08/2019

Therapy/Procedure

10Therapeutics
04/2021 - 04/2005
8Renal Dialysis (Hemodialysis)
11/2020 - 01/2007
7Catheters
01/2019 - 01/2007
4Cholecystectomy
01/2021 - 04/2012
3Splenectomy
04/2012 - 10/2007
2Endovascular Procedures
01/2019 - 09/2009
2Stents
12/2015 - 09/2009
2Esophagectomy
06/2013 - 01/2013
2Kidney Transplantation
06/2013 - 05/2006
2Pancreaticoduodenectomy
03/2012 - 01/2003
2Central Venous Catheters
09/2009 - 01/2007
1Immunotherapy
01/2022